Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers

Saskia Lisa Verhaart, Yasmin Abu-Ghanem, Sasja F Mulder, Sjoukje Oosting, Astrid Van Der Veldt, Susanne Osanto, Maureen J B Aarts, Danny Houtsma, Frank P J Peters, Gerard Groenewegen, Carla M L Van Herpen, Loes M Pronk, Metin Tascilar, Paul Hamberg, Maartje Los, Gerard Vreugdenhil, Marco Polee, Albert J Ten Tije, John B A G Haanen, Axel Bex*Alfonsus J van den Eertwegh

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers'. Together they form a unique fingerprint.

Medicine and Dentistry